Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national blog main
national top stories
boston blog main
boston top stories
national
president trump
san francisco blog main
san francisco top stories
alex azar
alphabet
boulder/denver blog main
boulder/denver top stories
broad institute of harvard and mit
brook byers
charles chu
consumer choice center
crispr
crispr cas14
david clement
deals
decheng capital
department of health and human services
detroit blog main
detroit top stories
diagnostic
donald trump
drug prices
drug pricing
fda
google
healthcare
importation
indiana blog main
indiana top stories
infectious disease
investing
kleiner perkins
mammoth biosciences
What
cheaper
3
×
administration
plan
trump
announced
available
awaited
based
big
bio
biopharma
biosciences
blueprint
canada
canadian
cas
costly
countries
crispr
department
develop
diagnostics
drug
drugs
excludes
expects
faster
floats
foreign
health
house
import
long
lowering
mammoth
medicare
medications
observers
ones
prescription
Language
unknown
unset
Current search:
cheaper
×
biotech
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
White House Floats Canadian Import Plan But Excludes Many Costly Drugs
@xconomy.com
5 years ago
Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones